Pharmalot.. Pharmalittle.. Good Morning
Good morning, everyone, and welcome to another working week. We hope the weekend respite was reinvigorating, because the usual routine of meetings and deadlines and what-not has returned. Although not for everyone on this side of the pond since a holiday is under way. In fact, we will have a light blogging schedule as we use the time to run our own version of R&D. Nonetheless, another day calls for another cup of stimulation. So please join us. Meanwhile, here are some tidbits. Enjoy and stay in touch…
Eli Lilly is ending development of its evacetrapib cholesterol-lowering drug because of insufficient efficacy; A recent FDA decision to approve painkillers for certain children as young as 11 has triggered fierce debate; Cigna agreed to drop its requirement that patients with HIV/AIDS get some of their medications exclusively through its mail-order pharmacy; and California Governor Jerry Brown signed a bill that sets the strictest government standards in the United States for the use of antibiotics in livestock production.